http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2573800-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28e51a279fa3515d1e152f2e1f0d8f9b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2015-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f52426915f9823aa71f5d4ac56cd5ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42491af6d42d63254ee8b198b802d811
publicationDate 2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2573800-C1
titleOfInvention Method for plastic repair of vast or subtotal eyelid defect, as well as totally lost eyelid
abstract FIELD: medicine. n SUBSTANCE: after a pathological lesion is removed, side walls of a penetration defect are extended by incising the separated conjunctive towards the adjoining conjunctival fornix, thereby forming a conjunctival flap. That is followed by forming and mobilising two vascular-pedicle muscular flaps of orbicular muscle tissues. The formed conjunctival flap and one of the muscular flaps are shifted until aligned with an eye fissure periphery; the flaps are fixed, whereas the tarsal plate defect is replaced by an autograft or endoprosthesis to be fixed. The second muscular flap is shifted similarly to the first muscular flap and fixed. After the skin defect is eliminated, the shifted tissues are fixed within the conjunctival fornix and in the entire area by means of U-sutures delivered through openings of hexagonal compression plates. Temporary blepharorrhaphy is performed; antiseptic agents are applied; a dressing is used to cover the defect area; the postoperative period involves taking out the stitches and removing the plates. n EFFECT: method enables achieving the total full-layer repair of the eyelid having vast or subtotal penetration defects, as well as is applicable in the repair of the totally lost eyelid due to providing the stable position of the tissues shifted onto the penetration defect area. n 7 cl, 3 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2639032-C1
priorityDate 2015-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2187290-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551813

Total number of triples: 16.